Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Inflammatory Bowel Diseases

isoxazoles has been researched along with Inflammatory Bowel Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cao, X; Feygin, A; Ivanov, AI; Lechuga, S; Naydenov, NG; Sun, L1
Heo, JD; Jeong, EJ; Ji, YK; Kim, NH; Kim, YN; Lee, SM; Rho, JR; Tu, NV1
Lee, TY; Liao, JF; Liu, HM1
López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L1
Braun, J; Sieper, J1

Other Studies

5 other study(ies) available for isoxazoles and Inflammatory Bowel Diseases

ArticleYear
A Novel Pharmacological Approach to Enhance the Integrity and Accelerate Restitution of the Intestinal Epithelial Barrier.
    Inflammatory bowel diseases, 2020, 08-20, Volume: 26, Issue:9

    Topics: Adherens Junctions; Cadherins; Cell Line, Tumor; Cell Membrane Permeability; Colon; Epithelial Cells; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Isoxazoles; Niacinamide; Signal Transduction; Up-Regulation

2020
Stereochemical Determination of Fistularins Isolated from the Marine Sponge
    Marine drugs, 2021, Mar-22, Volume: 19, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Caco-2 Cells; Coculture Techniques; Cytokines; Dinoprostone; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Isoxazoles; Molecular Structure; NF-kappa B; Nitric Oxide; Porifera; Signal Transduction; Stereoisomerism; Structure-Activity Relationship; THP-1 Cells; Tyrosine

2021
Farnesoid X receptor agonist GW4064 ameliorates lipopolysaccharide-induced ileocolitis through TLR4/MyD88 pathway related mitochondrial dysfunction in mice.
    Biochemical and biophysical research communications, 2017, 08-26, Volume: 490, Issue:3

    Topics: Animals; Colon; Ileum; Inflammatory Bowel Diseases; Isoxazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Myeloid Differentiation Factor 88; Receptors, Cytoplasmic and Nuclear; Toll-Like Receptor 4

2017
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
    Seminars in arthritis and rheumatism, 2015, Volume: 44, Issue:6

    Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis

2015
[Spondylarthritides].
    Zeitschrift fur Rheumatologie, 2006, Volume: 65, Issue:7

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Diagnostic Imaging; Etanercept; Female; HLA-B27 Antigen; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Physical Therapy Modalities; Receptors, Tumor Necrosis Factor; Spine; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine

2006